Essential Healthcare News
SEE OTHER BRANDS

Global take on healthcare and wellness news

Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on April 7, 2025

Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update

Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update

Auditor Licensing …

StarMab BioMed’s First-in-Class, Dual-Target Anti-Tumor Drug SM2275 for Novel Immunotherapy Receives FDA IND Approval

StarMab BioMed’s First-in-Class, Dual-Target Anti-Tumor Drug SM2275 for Novel Immunotherapy Receives FDA IND Approval

StarMab announces that US FDA has approved its Investigational New Drug (IND) application for SM2275, a novel dual-target nanobody-based anti-tumor therapy. BEIJING, CHINA, April 7, 2025 /⁨EINPresswire.com⁩/ -- Beijing StarMab BioMed Technology , Ltd. (“ …

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally address and …

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly …

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome injectable suspension …

CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)

CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)

NEW HYDE PARK, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, is in the Limited Distribution Network for Vanrafia™ (atrasentan), for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy ( …

Abacus Global Management Well-Positioned Amid Market Volatility

Abacus Global Management Well-Positioned Amid Market Volatility

ORLANDO, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, commented on the ongoing macro environment, noting that it remains well-positioned to …

Solésence Announces Uplisting to Nasdaq

Solésence Announces Uplisting to Nasdaq

Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today …

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, …

CVRx Reports Preliminary First Quarter 2025 Financial Results

CVRx Reports Preliminary First Quarter 2025 Financial Results

MINNEAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced certain preliminary unaudited first quarter 2025 revenue results. “While we continue to make significant progress …

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage

WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced the appointment of Dr. Shelly Gupta as Chief Medical Officer (“CMO”). Dr. Gupta will oversee …

Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission

Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission

WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, is unified by a commitment to advancing patient- …

LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025

LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025

BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a …

Arialief Review (PATIENT RESULTS EXPOSED): What Happened After 30 Days on This Nerve Pain Formula?

Arialief Review (PATIENT RESULTS EXPOSED): What Happened After 30 Days on This Nerve Pain Formula?

JUPITER, FL, April 07, 2025 (GLOBE NEWSWIRE) --  ARIALIEF Nerve pain is brutal. Whether it’s the persistent tingling, relentless burning, or sharp, electric jabs that come without warning—it can turn everyday life into a constant battle. More Than 30,000+ …

Inqtel Explores Potential in Cancer Therapy Research

Inqtel Explores Potential in Cancer Therapy Research

Inqtel is engaged in preclinical cancer therapy research. SYDNEY, NEW SOUTH WALES, AUSTRALIA, April 7, 2025 /⁨EINPresswire.com⁩/ -- Inqtel Pty Ltd Announces Expansion into Cancer Therapeutics, Exploring Novel Treatment with Potential Inqtel Pty Ltd, an …

Moringa Magic (EXPOSED): Why Doctors Are Finally Taking This Superfood Seriously in 2025

Moringa Magic (EXPOSED): Why Doctors Are Finally Taking This Superfood Seriously in 2025

DENVER, CO, April 07, 2025 (GLOBE NEWSWIRE) --  MORINGA MAGIC In a health market flooded with overhyped wellness fads and questionable herbal blends, Moringa Magic is exploding in popularity—and not just because of the hype. Real users are now claiming …

MESA LABS DECLARES QUARTERLY DIVIDEND

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The …

Virgin Islands Boating Expo Set to Open in less than 40 Days in St Thomas, USVI

Virgin Islands Boating Expo Set to Open in less than 40 Days in St Thomas, USVI

ST THOMAS, U.S. Virgin Islands, April 07, 2025 (GLOBE NEWSWIRE) -- The Virgin Islands Boat Expo (VIBE.vi), recognized as the Caribbean's premier boat show, is set to open its doors in just 50 days at the IGY Marine Yacht Haven Grande, St Thomas, USVI, May …

Integral BioSystems Announces Fast-Track Drug Development Services for those Exploring Proof of their Concepts

Integral BioSystems Announces Fast-Track Drug Development Services for those Exploring Proof of their Concepts

Boston area contract drug delivery firm Integral BioSystems announces fast-track rapid development services for start-up companies and entrepreneurs! BEDFORD, MA, UNITED STATES, April 7, 2025 /⁨EINPresswire.com⁩/ -- Integral BioSystems LLC, Boston area …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service